Abstract
Introduction
Approximately 5 % of all cancer cases are hereditary. Cancer genetic counseling assesses individual and family risks of cancer, conducts genetic studies, interprets results, and advises patients regarding strategies for prevention and risk reduction. Currently, many networks of hereditary cancer genetic counseling units (HCGCUs) are integrated in the medical oncology services of most Spanish hospitals, which are comprised of multidisciplinary teams and offer high-quality care for the treatment of hereditary cancer.
Materials and methods
The Spanish Society of Medical Oncology (SEOM) analyzed key issues involving the integration of HCGCUs into the National Health Service. These included basic compliance issues by these units regarding their operation and organization, as well as prerequisites in quality control thereof.
Results
This document describes the specific roles and clinical processes performed in HCGCUs in addition to basic services provided by molecular diagnostic laboratories. It also provides a summary on the coordination of care across different levels for patients and families with hereditary cancers. Finally, this document describes the human and material resources needed for the organization of HCGCUs.
Conclusions
SEOM has been a pioneer in the creation and development of HCGCUs. This paper seeks to ensure high-quality care to individuals and families with inherited susceptibility to cancer in Spain.
Similar content being viewed by others
References
Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2006) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer 5(1):61–75
Davies S, Royal College of Physicians of London (1998) Commissioning clinical genetics services: a report from the Clinical Genetics Committee of the Royal College of Physicians of London. Royal College of Physicians, London
Offit K (1998) Clinical cancer genetics: risk counseling and management. Wiley-Lis Inc, New York
Ley 14/2007, 3 July, of Biomedical Research
Clinical Practice Guidelines. Familial aspects of cancer. A guide to clinical practice. National Health and Medical Research Council-NHMRC-, Australia, November 1999. ISBN: 1 86496 0205
Pichert G (2004) Harnessing the potential of cancer genetics in healthcare. Lancet Oncol 5:626–632
Wonderling D, Hopwood P, Cull A, Douglas F, Watson M, Burn J, McPherson K (2001) A descriptive study of UK cancer genetic services: an emerging clinical response to the new genetics. Brit J Cancer 85(2):166–170
Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, Wollins DS, Garber JE, Brown P, Kramer BS (2009) American Society of Clinical Oncology Policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol 27:986–993
Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K (2010) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28(5):893–901
Graña B, Lastra E, Llort G, Brunet J, Isla D (2011) SEOM Clinical Guidelines on hereditary cancer. Clin Transl Oncol 13(8):580–586
Hereditary Cancer II edition. Spanish Society of Medical Oncology (SEOM) in collaboration with Roche Institute. Madrid 2010. ISBN: 978-84-614-5232-3
Acknowledgments
We wish to thank all of the following members of the Hereditary Cancer Section Executive Committee for their constructive support in preparing this report: Dr. Judith Balmaña (Medical Oncology Service, Hospital Valle de Hebrón), Dr. Begoña Graña (Medical Oncology Service, Hospital Arquitecto Marcide of La Coruña) and Dr. Santiago González Santiago (Medical Oncology Service, Hospital San Pedro de Alcántara of Cáceres). We also wish to thank the following members of the Advisory Board of the Section who helped us with their valuable views: Dr. Miguel Urioste (Human Cancer Genetics Programme, CNIO, Madrid), Dr. Angel Alonso (Clinical Genetics Service, Hospital Virgen del Camino of Pamplona), Dr. Joan Brunet (Medical Oncology Service, Hospital Josep Trueta of Girona), and Dr. Pedro Pérez-Segura (Medical Oncology Service, Hospital Clínico San Carlos of Madrid).
Conflict of interest
The authors don’t have any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors have equally contributed for the preparation of this article and they are on behalf of the Hereditary Cancer Section of the Spanish Society of Medical Oncology (SEOM).
Rights and permissions
About this article
Cite this article
Lastra-Aras, E., Robles-Díaz, L., Guillén-Ponce, C. et al. SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs). Clin Transl Oncol 15, 20–25 (2013). https://doi.org/10.1007/s12094-012-0920-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0920-1